Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H12BrN3O4 |
InChIKeyWTZFFWJZFQVAGV-UHFFFAOYSA-N |
CAS Registry339004-08-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 02 Mar 2018 |